Unternehmen AbbVie Inc.

Unternehmen AbbVie Inc.

A1J84E

US00287Y1091

ABBV

Pharmazeutika

Analystenschätzungen

Aktien

A1J84E

US00287Y1091

ABBV

Pharmazeutika

Analystenschätzungen

Kurzporträt

Umsatz nach Geschäftsbereich

Umsatz je Region

Manager

Aufsichtsräte

Anteilsklasse

Aktionäre

Unternehmensbesitz

Unternehmenskontakt

Konzerngesellschaften

Sektor

Umsatz nach Geschäftsbereich

Umsatz je Region

Ratings für AbbVie Inc.

Verlauf des Gewinns je Aktie

Quartalsgewinne - Abweichungsrate

Sektor Pharmazeutika - Andere

Kurzporträt

Umsatz nach Geschäftsbereich

Umsatz je Region

Manager

Aufsichtsräte

Anteilsklasse

Aktionäre

Unternehmensbesitz

Unternehmenskontakt

Konzerngesellschaften

Sektor

Umsatz nach Geschäftsbereich

Umsatz je Region

Ratings für AbbVie Inc.

Verlauf des Gewinns je Aktie

Quartalsgewinne - Abweichungsrate

Sektor Pharmazeutika - Andere

Markt geschlossen - Nyse Andere Börsenplätze 22:00:02 18.04.2024			% 5 Tage	% 1. Jan.
164,7 ^USD	+0,25 %		-1,71 %	+6,25 %

12.04.	WOCHENVORSCHAU: Termine bis 26. April 2024	DP
12.04.	AbbVie sagt, dass Phase-3-Zwischendaten die langfristige Wirksamkeit und Sicherheit des Migränemittels unterstützen	MT

AbbVie Inc. ist auf die Erforschung und Entwicklung von therapeutischen Medikamenten spezialisiert. Die Produkte des Unternehmens sind für die Behandlung von rheumatoider Arthritis, Psoriasis, Morbus Crohn, Schilddrüsenerkrankungen, Parkinson, HIV, Komplikationen bei Mukoviszidose, niedrigem Testosteronspiegel und Komplikationen im Zusammenhang mit chronischen Nierenerkrankungen bestimmt.
Der Nettoumsatz verteilt sich geografisch wie folgt: Vereinigte Staaten (77,1%), Deutschland (2,3%), Kanada (2%), Japan (1,9%), China (1,7%), Frankreich (1,4%), Spanien (0,9%), Italien (0,9%), Australien (0,9%), Brasilien (0,8%), Vereinigtes Königreich (0,8%) und andere (9,3%).

Mitarbeiterzahl: 50 000

USD in Millionen	2022	Gewichtung	2023	Gewichtung	Delta
Immunology 48,1 %	28 924	49,8 %	26 136	48,1 %	-9,64 %
Neuroscience 14,2 %	6 528	11,2 %	7 717	14,2 %	+18,21 %
Other 12,6 %	7 991	13,8 %	6 841	12,6 %	-14,39 %
Oncology 10,9 %	6 577	11,3 %	5 915	10,9 %	-10,07 %
Aesthetics 9,7 %	5 333	9,2 %	5 294	9,7 %	-0,73 %
Eye Care 4,4 %	2 701	4,7 %	2 415	4,4 %	-10,59 %

USD in Millionen	2022	Gewichtung	2023	Gewichtung	Delta
United States 77,1 %	45 713	78,7 %	41 883	77,1 %	-8,38 %
All Other Countries 9,3 %	4 837	8,3 %	5 042	9,3 %	+4,24 %
Germany 2,3 %	1 340	2,3 %	1 266	2,3 %	-5,52 %
Canada 2,0 %	1 159	2,0 %	1 076	2,0 %	-7,16 %
Japan 1,9 %	956	1,6 %	1 008	1,9 %	+5,44 %
China 1,7 %	912	1,6 %	950	1,7 %	+4,17 %
France 1,4 %	787	1,4 %	780	1,4 %	-0,89 %
Spain 0,9 %	506	0,9 %	501	0,9 %	-0,99 %
Italy 0,9 %	444	0,8 %	484	0,9 %	+9,01 %
Australia 0,9 %	508	0,9 %	472	0,9 %	-7,09 %
Brazil 0,8 %	430	0,7 %	439	0,8 %	+2,09 %
United Kingdom 0,8 %	462	0,8 %	417	0,8 %	-9,74 %

Manager	Titel	Alter	Seit
Richard Gonzalez CEO	Chief Executive Officer	70	01.01.13
Scott Reents DFI	Director of Finance/CFO	57	01.01.13
Robert Michael PSD	President	53	01.01.12
Thomas Hudson CTO	Chief Tech/Sci/R&D Officer	62	01.01.16
Azita Saleki-Gerhardt COO	Chief Operating Officer	60	01.01.13
Todd D. Bosse IRC	Investor Relations Contact	-	01.12.21
Roopal Thakkar PRN	Corporate Officer/Principal	-	01.01.03
Kevin Buckbee AUD	Comptroller/Controller/Auditor	58	01.03.23
Perry Siatis LAW	General Counsel	-	01.10.22
Carrie Strom PRN	Corporate Officer/Principal	-	08.05.20

Aufsichtsräte	Titel	Alter	Seit
Roxanne Austin BRD	Director/Board Member	63	01.01.13
Edward Rapp BRD	Director/Board Member	66	01.01.13
Frederick Waddell BRD	Director/Board Member	70	01.01.13
Glenn Tilton BRD	Director/Board Member	75	01.01.13
Richard Gonzalez CEO	Chief Executive Officer	70	01.01.13
Thomas Freyman BRD	Director/Board Member	69	08.05.20
William H. L. Burnside BRD	Director/Board Member	72	01.01.13
Brett Hart BRD	Director/Board Member	54	01.01.16
Robert Alpern BRD	Director/Board Member	73	01.01.13
Robert Michael PSD	President	53	01.01.12

	Vote	Menge	Streubesitz	Konzerneigene Aktien	Total Float
Aktie A	1	1 827 752 337	1 768 404 283 ( 96,75 %)	57 105 354 ( 3,124 %)	96,75 %

Name	Aktien	%	Bewertung
Vanguard Fiduciary Trust Co. 9,080 %	160 398 331	9,080 %	29 209 Mio $
BlackRock Advisors LLC 6,295 %	111 194 482	6,295 %	20 249 Mio $
STATE STREET CORPORATION 4,427 %	78 200 866	4,427 %	14 240 Mio $
JPMorgan Investment Management, Inc. 2,818 %	49 783 234	2,818 %	9 066 Mio $
Capital Research & Management Co. (International Investors) 2,547 %	44 988 183	2,547 %	8 192 Mio $
Geode Capital Management LLC 2,096 %	37 017 486	2,096 %	6 741 Mio $
Eaton Vance Management 1,927 %	34 048 660	1,927 %	6 200 Mio $
Capital Research & Management Co. (Global Investors) 1,715 %	30 302 654	1,715 %	5 518 Mio $
BlackRock Life Ltd. 1,616 %	28 543 244	1,616 %	5 198 Mio $
Charles Schwab Investment Management, Inc. 1,384 %	24 451 975	1,384 %	4 453 Mio $

Name	Aktien	%	Bewertung
Caixa DTVM SA 0,001471 %	415 822	0,001471 %	5 Mio $
Bram Bradesco Asset Management S/A DTVM 0,000227 %	64 298	0,000227 %	732 313 $
XP Allocation Asset Management Ltda. 0,000004 %	1 119	0,000004 %	12 745 $

Name	Aktien	%	Bewertung
CARISMA THERAPEUTICS, INC. 6,81%	2 749 855	6,81%	6 242 171 $

AbbVie, Inc.

1 North Waukegan Road

60064-6400, North Chicago

+847 932 7900

http://www.abbvie.com

Name	Kategorie und Branche
Allergan Norden AB
AbbVie Bahamas Ltd.
AbbVie Biotechnology Ltd.
AbbVie Corp.
AbbVie Endocrine, Inc.
AbbVie GK
AbbVie International SARL
AbbVie Investments SARL
AbbVie Ireland NL BV
AbbVie Biopharmaceuticals GmbH
AbbVie Logistics BV AbbVie Logistics BV Medical DistributorsDistribution Services Part of AbbVie, Inc., AbbVie Logistics BV is a wholesaler of pharmaceutical products. The private company is based in Zwolle, Netherlands.	Medical Distributors
AbbVie Overseas SARL
AbbVie Pty Ltd.
AbbVie Srl AbbVie Srl Pharmaceuticals: MajorHealth Technology AbbVie Srl is a biopharmaceutical company. It manufactures and distributes pharmaceutical products. The company is headquartered in Campoverde di Aprilia, Italy.	Pharmaceuticals: Major
AbbVie Ireland Unlimited Co.
AbbVie Ltd.
AbbVie AG
AbbVie Deutschland GmbH & Co. KG AbbVie Deutschland GmbH & Co. KG BiotechnologyHealth Technology Part of AbbVie, Inc., AbbVie Deutschland GmbH & Co. KG is a German company that focuses on treating plaque psoriasis, a chronic inflammatory skin disease that cannot be cured but can be managed effectively. The private company is based in Wiesbaden, Germany. The CEOs of the company are Thomas Scheidmeir, Stefan Simianer.	Biotechnology
AbbVie Spain SL
AbbVie Farmacéuticos SA de CV AbbVie Farmacéuticos SA de CV BiotechnologyHealth Technology Part of AbbVie, Inc., AbbVie Farmacéuticos SA de CV engages in research and development of medicines. The private company is based in Mexico City, Mexico.	Biotechnology
AbbVie Pharmaceuticals BV
AbbVie Pte Ltd. AbbVie Pte Ltd. Pharmaceuticals: MajorHealth Technology AbbVie Pte Ltd. operates as a research-based pharmaceutical company. The company was founded in January 1, 2013 and is headquartered in Singapore, Singapore.	Pharmaceuticals: Major
AbbVie SAS AbbVie SAS Pharmaceuticals: MajorHealth Technology Part of AbbVie, Inc., AbbVie SAS is a Colombian company that develops drugs and pharmaceutical products. The private company is based in Bogota, Colombia.	Pharmaceuticals: Major
AbbVie Ltd. (New Zealand)
AbbVie Japan Holdings BV
AbbVie UK Biopharmaceuticals Ltd. AbbVie UK Biopharmaceuticals Ltd. Miscellaneous Commercial ServicesCommercial Services Part of AbbVie, Inc., AbbVie UK Biopharmaceuticals Ltd. provides business support services. The private company is based in St. Helier, UK.	Miscellaneous Commercial Services
AbbVie Research BV
AbbVie Products GmbH
AbbVie Pharmaceutical Trading (Shanghai) Co. Ltd.
AbbVie AS
AbbVie Farmacêutica Ltda. AbbVie Farmacêutica Ltda. Pharmaceuticals: MajorHealth Technology Part of AbbVie, Inc., AbbVie Farmacêutica Ltda. The private company is located in Brazil. is a Brazilian company that manufactures pharmaceutical products.	Pharmaceuticals: Major
AbbVie sro AbbVie sro Pharmaceuticals: MajorHealth Technology Part of AbbVie, Inc., AbbVie sro is a Czech company that develops and manufactures pharmaceutical products. The company is located in Czechia.	Pharmaceuticals: Major
Pharmacyclics Switzerland GmbH Pharmacyclics Switzerland GmbH Pharmaceuticals: MajorHealth Technology Part of AbbVie, Inc., Pharmacyclics Switzerland GmbH is a Swiss company that manufactures pharmaceutical products. The private company is located in Switzerland.	Pharmaceuticals: Major
AbbVie Operations Singapore Pte Ltd. AbbVie Operations Singapore Pte Ltd. BiotechnologyHealth Technology Part of AbbVie, Inc., AbbVie Operations Singapore Pte Ltd. is a Singaporean company that develops therapies and clinical medicines. The private company is located in Singapore.	Biotechnology
AbbVie Lda. AbbVie Lda. Pharmaceuticals: MajorHealth Technology Part of AbbVie, Inc., AbbVie Lda. The private company is located in Portugal. is a Portuguese company that manufactures and wholesales pharmaceutical products.	Pharmaceuticals: Major
AbbVie Sp zoo AbbVie Sp zoo Pharmaceuticals: MajorHealth Technology Part of AbbVie, Inc., AbbVie Sp zoo is a Polish company that manufactures pharmaceutical products. The private company is located in Poland.	Pharmaceuticals: Major
AbbVie Polska Sp zoo AbbVie Polska Sp zoo Pharmaceuticals: MajorHealth Technology Part of AbbVie, Inc., AbbVie Polska Sp zoo is a Polish company that develops and manufactures medical products. The private company is located in Poland.	Pharmaceuticals: Major
AbbVie BV AbbVie BV Pharmaceuticals: MajorHealth Technology Part of AbbVie, Inc., AbbVie BV is a Dutch company that manufactures pharmaceutical products. The private company is located in the Netherlands.	Pharmaceuticals: Major
AbbVie Sdn. Bhd. AbbVie Sdn. Bhd. Pharmaceuticals: MajorHealth Technology Part of AbbVie, Inc., AbbVie Sdn. The private company is located in Malaysia. Bhd. is a Malaysian company that discovers, develops, manufactures, and sells proprietary pharmaceutical products.	Pharmaceuticals: Major
AbbVie Oy AbbVie Oy Pharmaceuticals: MajorHealth Technology Part of AbbVie, Inc., AbbVie Oy is a Finnish company that manufactures and wholesales pharmaceutical products. The private company is based in Espoo, Finland.	Pharmaceuticals: Major
AbbVie (Gibraltar) Ltd. AbbVie (Gibraltar) Ltd. Pharmaceuticals: MajorHealth Technology Part of AbbVie, Inc., AbbVie (Gibraltar) Ltd. is a company that manufactures pharmaceutical products. The company is located in Gibraltar.	Pharmaceuticals: Major
AbbVie Gyogyszerkereskedelmi Kft. AbbVie Gyogyszerkereskedelmi Kft. Pharmaceuticals: MajorHealth Technology Part of AbbVie, Inc., AbbVie Gyogyszerkereskedelmi Kft. is a Hungarian biopharmaceutical company that operates in Hungary.	Pharmaceuticals: Major
Abbvie Manufacturing Management Unlimited Co. Abbvie Manufacturing Management Unlimited Co. Miscellaneous Commercial ServicesCommercial Services Part of AbbVie, Inc., AbbVie Manufacturing Management Unlimited Co. is an Irish company that provides business and management consulting services. The private company is based in Dublin, Ireland. Founded in 2012.	Miscellaneous Commercial Services
AbbVie Ltd. (South Korea) AbbVie Ltd. (South Korea) Pharmaceuticals: MajorHealth Technology Part of AbbVie, Inc., AbbVie Ltd. is a South Korean company that manufactures pharmaceutical products. The private company is located in South Korea.	Pharmaceuticals: Major
S.C. AbbVie SRL S.C. AbbVie SRL Pharmaceuticals: MajorHealth Technology Part of AbbVie, Inc., S.C. AbbVie SRL is a Romanian company that manufactures pharmaceutical products. The private company is located in Romania.	Pharmaceuticals: Major
AbbVie doo (Slovenia) AbbVie doo (Slovenia) Pharmaceuticals: MajorHealth Technology Part of AbbVie, Inc., AbbVie doo (Slovenia) is a Slovene company that researches and manufactures pharmaceutical products. The private company is located in Slovenia.	Pharmaceuticals: Major
AbbVie SRO (Slovakia) AbbVie SRO (Slovakia) BiotechnologyHealth Technology Part of AbbVie, Inc., AbbVie SRO (Slovakia) is a company that engages in research and development in the treatment of serious diseases that affect people's lives. The company is located in Slovakia.	Biotechnology
AbbVie SARL (Luxembourg) AbbVie SARL (Luxembourg) BiotechnologyHealth Technology Part of AbbVie, Inc., AbbVie SARL is a pharmaceutical company based in Luxembourg, Luxembourg. The Luxembourger company engages in research, development, and commercialization of pharmaceuticals.	Biotechnology
AbbVie A/S (Denmark) AbbVie A/S (Denmark) Pharmaceuticals: MajorHealth Technology Part of AbbVie, Inc., AbbVie A/S is a Danish biopharmaceutical company that develops and manufactures medicines. The private company is based in Copenhagen, Denmark.	Pharmaceuticals: Major
AbbVie Pharmaceuticals SCA
AbbVie Central Finance BV
AbbVie Foundation AbbVie Foundation Miscellaneous Commercial ServicesCommercial Services AbbVie Foundation operates as a biopharmaceutical company. The non-profit company is based in North Chicago, IL.	Miscellaneous Commercial Services
AbbVie Finance Ltd.
AbbVie International Holdings Unlimited Co. AbbVie International Holdings Unlimited Co. MiscellaneousMiscellaneous Part of AbbVie, Inc., AbbVie International Holdings Unlimited Co. is an Irish company that functions as an investment holding company.	Miscellaneous
AbbVie Biopharmaceuticals GmbH Taiwan Branch
Fournier Laboratories Ireland Ltd.
Allergan Pharmaceuticals Ireland ULC Allergan Pharmaceuticals Ireland ULC Pharmaceuticals: MajorHealth Technology Allergan Pharmaceuticals Ireland operates as a sterile pharmaceutical ophthalmic and biologics plant. It offers chemistry, microbiology laboratories and research and development support activities. The company was founded in 1977 and is headquartered in Westport, Ireland.	Pharmaceuticals: Major
AbbVie Ireland Holdings Unlimited Co.
AbbVie Ltd. (Bermuda)
AbbVie Ltd. (United Kingdom) AbbVie Ltd. (United Kingdom) Miscellaneous Commercial ServicesCommercial Services Part of AbbVie, Inc., AbbVie Ltd. (United Kingdom) is a British company that develops advanced therapies through research and innovation. The private company is based in Maidenhead, UK and was founded in 2012.	Miscellaneous Commercial Services
AbbVie Finance BV

Trading Rating

Investment Rating

ESG Refinitiv

C+

Mehr Ratings

Verkaufen

Kaufen

Durchschnittl. Empfehlung

AUFSTOCKEN

Anzahl Analysten

Letzter Schlusskurs

164,2 USD

Mittleres Kursziel

184 USD

Abstand / Durchschnittliches Kursziel

+12,00 %

Analystenschätzungen

Entwicklung der Schätzungen

Unternehmenstermine

	% 1. Jan.	Kap.
ABBVIE INC.	+6,25 %	291 Mrd.
ELI LILLY AND COMPANY	+27,97 %	676 Mrd.
NOVO NORDISK A/S	+23,58 %	554 Mrd.
JOHNSON & JOHNSON	-7,02 %	349 Mrd.
MERCK & CO., INC.	+14,85 %	318 Mrd.
ASTRAZENECA PLC	+2,96 %	210 Mrd.
NOVARTIS AG	-0,41 %	204 Mrd.
ROCHE HOLDING AG	-10,02 %	194 Mrd.
PFIZER, INC.	-11,81 %	144 Mrd.
AMGEN INC.	-8,80 %	142 Mrd.

Pharmazeutika - Andere

Gesundheitspflege

Pharmazie und Biotechnologie

Pharmazie und Biotechnologie

Pharmazeutika

Pharmazeutika - Andere